By Jason Karlawish
On the morning of June 7th, 2021, the U.S. Food and Drug Administration (FDA) approved Biogen’s drug aducanumab (marketed as Aduhelm) for the treatment of Alzheimer’s disease. Alzheimer’s Association President Harry Johns called this decision “historic.” For … Read the article
The post The Despair of Persons Living With Alzheimer’s Disease appeared first on The History Reader.
0 Comments